Nose spray showdown: which sedative works best for anxious children?
NCT ID NCT07180095
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests two different nose sprays—dexmedetomidine and ketamine—to see which one better calms children aged 2 to 6 before surgery. Sixty kids will receive one of the two sprays, and researchers will measure how sleepy they get and how easily they separate from their parents. The goal is to find a safer, more effective way to reduce preoperative anxiety in young patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intranasal dexmedetomidine and intranasal ketamine
- What this could lead to
- If it works, this could point toward a better way to calm children before surgery, reducing anxiety and making separation from parents easier.
- What could go wrong
- This is a small, early-phase trial with only 60 children, so results may not apply to all kids. Both drugs can cause side effects like low blood pressure or slow heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 to 6 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * American society of Anesthesiologist (ASA) class-I and II * Children 2-6 years of age undergoing elective surgery Exclusion Criteria: * Known hypersensitivity to study drugs * Refusal of consent * Known renal, hepatic or cardiac dysfunction * Nasal deformity or pathology * Recent upper respiratory infection (within 2 weeks) * Children undergoing neurosurgery or ophthalmic surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiolytic effect are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nasal spray make surgery less scary for kids?
- Can a small dose of ketamine make colonoscopy sedation safer?
- Can a gentle oxygen boost make lung biopsies safer and faster?
- A Mother's voice as medicine? trial tests comforting effect on ventilated children
- A single score may spot breathing trouble before it's too late in sedated children
- Mapping the waking brain: how ICU patients emerge from sedation